Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38942 POSTS 0 COMMENTS
The prevalence of arthritis was 22.8 percent in U.S. adults in 2017

CDC: Prevalence of Arthritis 22.8 Percent in U.S. Adults in 2017

0
Adults with arthritis in southeastern states have highest prevalence of severe joint pain, physical inactivity
EndoPredict is prognostic for distant recurrence in women with estrogen receptor-positive

Test Predicts Benefit of Chemo in ER+, HER2− Breast Cancer

0
EndoPredict, a multigene test, helps predict whether adjuvant chemotherapy would be beneficial
For patients with hepatocellular carcinoma

Percutaneous Ablation in Liver Cancer Tied to Better Outcomes

0
Intervention linked to better short-term outcomes versus surgical procedures
Ruzurgi (amifampridine) tablets are now approved to treat Lambert-Eaton myasthenic syndrome in children aged 6 to 17 years

FDA Approves Ruzurgi for Children With Rare Autoimmune Disorder

0
Ruzurgi previously approved for treatment in adults with Lambert-Eaton myasthenic syndrome
Pregnancy-related deaths occur during pregnancy

CDC: Pregnancy-Related Deaths Occur Before, During, Postpartum

0
60 percent of pregnancy-related deaths determined to be preventable, with multiple contributory factors
Administration of a single dose of oral aspirin prior to fecal immunochemical testing does not increase test sensitivity for detecting advanced colorectal neoplasms

Oral Aspirin Does Not Up FIT Test Sensitivity for ID’ing CRC

0
Sensitivity not significantly increased in aspirin versus placebo group at two cutoffs
The burden of heart failure-related cardiovascular disease mortality is increased among young and middle-aged blacks

Burden of Heart Failure-Related CVD Mortality Higher in Blacks

0
Burden significantly higher among young and middle-aged black versus white men and women
Many radiology residents do not accurately recognize child abuse

Radiology Residents Often Miss Child Abuse

0
Variation in correct call rate from 1 to 81 percent per year during 2014 to 2018
A single dose of gentamicin is an appropriate second-line therapy for gonorrhea resistant to a single dose of ceftriaxone

Gentamicin Appropriate Second-Line Therapy to Ceftriaxone for Gonorrhea

0
Two weeks after treatment, infection cleared for 98, 91 percent treated with ceftriaxone versus gentamicin
In a new American Academy of Neurology guideline published in the May 7 issue of Neurology

Recommendations Issued for Treating Tourette Syndrome

0
Guidelines based on systematic review, focus on individualized treatment decisions